Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer

<p>Abstract</p> <p>Background</p> <p>T-cell based immunotherapy for lung cancer (LC) could be a promising and novel therapeutic approach. Six-transmembrane epithelial antigen of the prostate (STEAP) and the polycomb group protein enhancer of zeste homolog 2 (EZH2) are h...

Full description

Bibliographic Details
Main Authors: Kimura Shoji, Sato Keisuke, Aoki Naoko, Matsuda Yoshiya, Kumai Takumi, Hayashi Satoshi, Kitada Masahiro, Tateno Masatoshi, Celis Esteban, Kobayashi Hiroya
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Journal of Translational Medicine
Online Access:http://www.translational-medicine.com/content/9/1/191